Patient-Derived iPSC-MSC Modelling Reveals Reversible GSK3-Mediated Suppression of Mesenchymal Lineage Differentiation in Legg-Calvé-Perthes Disease.

Seol B, Lim HJ, Song CL, Lee J, Cho YS

Open source

DOI
10.1111/jcmm.71350
Published
2026 Sep
Container
Journal of cellular and molecular medicine
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/jcmm.71350,
  title = {Patient-Derived iPSC-MSC Modelling Reveals Reversible GSK3-Mediated Suppression of Mesenchymal Lineage Differentiation in Legg-Calvé-Perthes Disease.},
  author = {Seol B and Lim HJ and Song CL and Lee J and Cho YS},
  year = {2026},
  journal = {Journal of cellular and molecular medicine},
  doi = {10.1111/jcmm.71350},
  url = {https://doi.org/10.1111/jcmm.71350}
}

RIS

TY  - JOUR
TI  - Patient-Derived iPSC-MSC Modelling Reveals Reversible GSK3-Mediated Suppression of Mesenchymal Lineage Differentiation in Legg-Calvé-Perthes Disease.
AU  - Seol B
AU  - Lim HJ
AU  - Song CL
AU  - Lee J
AU  - Cho YS
PY  - 2026
JO  - Journal of cellular and molecular medicine
DO  - 10.1111/jcmm.71350
UR  - https://doi.org/10.1111/jcmm.71350
ER  - 

APA

B, S., HJ, L., CL, S., J, L., & YS, C. (2026). Patient-Derived iPSC-MSC Modelling Reveals Reversible GSK3-Mediated Suppression of Mesenchymal Lineage Differentiation in Legg-Calvé-Perthes Disease.. Journal of cellular and molecular medicine. https://doi.org/10.1111/jcmm.71350

Source records